You are here: Home » News-CM » Companies » Results
Business Standard

Jenburkt Pharmaceuticals standalone net profit rises 173.64% in the March 2017 quarter

Capital Market 

Sales rise 24.19% to Rs 27.21 crore

Net profit of Jenburkt Pharmaceuticals rose 173.64% to Rs 3.53 crore in the quarter ended March 2017 as against Rs 1.29 crore during the previous quarter ended March 2016. Sales rose 24.19% to Rs 27.21 crore in the quarter ended March 2017 as against Rs 21.91 crore during the previous quarter ended March 2016.

For the full year,net profit rose 24.86% to Rs 13.46 crore in the year ended March 2017 as against Rs 10.78 crore during the previous year ended March 2016. Sales rose 10.72% to Rs 102.90 crore in the year ended March 2017 as against Rs 92.94 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales27.2121.91 24 102.9092.94 11 OPM %20.9112.37 -19.1817.71 - PBDT6.453.46 86 22.0918.81 17 PBT6.002.91 106 20.3016.82 21 NP3.531.29 174 13.4610.78 25

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, June 14 2017. 15:55 IST
RECOMMENDED FOR YOU